Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARFILZOMIB vs CARISOPRODOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARFILZOMIB vs CARISOPRODOL: Safety Overview

Metric CARFILZOMIB CARISOPRODOL
Total FAERS Reports 21,814 2,660
Deaths Reported 3,448 1,332
Death Rate 15.8% 50.1%
Hospitalizations 7,502 432
Average Patient Age 64.7 yrs 48.1 yrs
% Female Patients 42.6% 63.6%
FDA Approval Date Jul 20, 2012 Approved Prior to Jan 1, 1982
Manufacturer Onyx Pharmaceuticals, Inc. ScieGen Pharmaceuticals, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription